Skip to main content

Advertisement

The FDA pulls key DEI initiative for cancer studies from its website

Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration website. (Getty Images)
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration website. (Getty Images)

Related:

Advertisement

Advertisement

Listen Live